UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 804

Sortiert nach

Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies

European journal of nuclear medicine and molecular imaging, 2019-09, Vol.46 (10), p.2178-2189

2019

Volltextzugriff (PDF)

Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathy

PloS one, 2013-08, Vol.8 (8), p.e72301-e72301

2013

Volltextzugriff (PDF)

Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice

Proceedings of the National Academy of Sciences - PNAS, 2007-06, Vol.104 (23), p.9810-9815

2007

Volltextzugriff (PDF)

Engineering amyloid-like assemblies from unstructured peptides via site-specific lipid conjugation

PloS one, 2014-09, Vol.9 (9), p.e105641

2014

Volltextzugriff (PDF)

Discovery and characterization of novel indole and 7-azaindole derivatives as inhibitors of β-amyloid-42 aggregation for the treatment of Alzheimer’s disease

Bioorganic & medicinal chemistry letters, 2017-03, Vol.27 (6), p.1405-1411

2017

Volltextzugriff (PDF)

Sequence-independent Control of Peptide Conformation in Liposomal Vaccines for Targeting Protein Misfolding Diseases

The Journal of biological chemistry, 2011-04, Vol.286 (16), p.13966-13976

2011

Volltextzugriff (PDF)

Novel Phospho-Tau Monoclonal Antibody Generated Using a Liposomal Vaccine, with Enhanced Recognition of a Conformational Tauopathy Epitope

Journal of Alzheimer's disease, 2017-01, Vol.56 (2), p.585

2017

Volltextzugriff (PDF)

TLR4- and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T cell–independent isotype switch in mice

Blood, 2013-01, Vol.121 (1), p.85-94

2013

Volltextzugriff (PDF)

A liposomal anti-phospho-tau vaccine demonstrates higher immunogenicity and specificity than a classical peptide vaccine approach

Alzheimer's & dementia, 2013-07, Vol.9 (4), p.P326-P326

2013

Volltextzugriff (PDF)

Immunization with liposome-anchored pegylated peptides modulates doxorubicin sensitivity in P-glycoprotein-expressing P388 cells

Cancer letters, 2007-11, Vol.257 (2), p.165-171

2007

Volltextzugriff (PDF)

Phospho-tau–specific vaccine for the treatment of tau pathology

Alzheimer's & dementia, 2012-07, Vol.8 (4), p.P398-P399

2012

Volltextzugriff (PDF)

Novel phospho-Tau specific monoclonal antibodies for the treatment of Tau-mediated pathology

Alzheimer's & dementia, 2011-07, Vol.7 (4), p.S480-S480

2011

Volltextzugriff (PDF)

The safety profile of ACI-24, an oligo-specific amyloid beta vaccine, demonstrated decrease of large microbleedings in brain of aged Alzheimer's disease mouse model

Alzheimer's & dementia, 2009-07, Vol.5 (4), p.P425-P426

2009

Volltextzugriff (PDF)

Nucleic acid binding properties of thyminyl and adeninyl pyrrolidine-amide oligonucleotide mimics (POM)

Chemical communications (Cambridge, England), 2004-03 (5), p.516-517

2004

Volltextzugriff (PDF)

Design, synthesis, conformational analysis and nucleic acid hybridisation properties of thymidyl pyrrolidine-amide oligonucleotide mimics (POM)

Organic & biomolecular chemistry, 2003-10, Vol.1 (19), p.3277-3292

2003

Volltextzugriff (PDF)

Nucleic acid binding properties of thyminyl and adeninyl pyrrolidine-amide oligonucleotide mimics (POM)This paper is dedicated to Professor Heinz G. Floss on the occasion of his 70th birthday.Electronic supplementary information (ESI) available: experimental details. See http://www.rsc.org/suppdata/cc/b3/b315768g

Chemical communications (Cambridge, England), 2004-02 (5), p.516

2004

Volltextzugriff (PDF)

An Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome

PloS one, 2016-03, Vol.11 (3), p.e0152471-e0152471

2016

Volltextzugriff (PDF)

Design, synthesis, conformational analysis and nucleic acid hybridisation properties of thymidyl pyrrolidine-amide oligonucleotide mimics (POM)Electronic supplementary information (ESI) available: experimental details (16 Figures, 3 Tables). See http://www.rsc.org/suppdata/ob/b3/b306156f

Organic & biomolecular chemistry, 2003-09, Vol.1 (19), p.3277

2003

Volltextzugriff (PDF)

Discovery and preclinical characterization of 18FPI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies

European journal of nuclear medicine and molecular imaging, 2019-09, Vol.46 (10), p.2178

2019

Volltextzugriff (PDF)

Synthesis and nucleic-acid-binding properties of sulfamide- and 3 '-N-sulfamate-modified DNA

Perkin 1 : an international journal of organic and bio-organic chemistry, 2002-02 (4), p.485-495

2002

Volltextzugriff (PDF)

A general route for the synthesis of triazacyclononane functionalised with one, two or three pendant phosphine arms: crystal structure of [Zn2L2Cl3][ClO4], L =N-(diphenylphosphinopropyl)-1,4,7-triazacyclononane

Chemical communications (Cambridge, England), 1996 (15), p.1817

1996

Volltextzugriff (PDF)

Synthesis and nucleic-acid-binding properties of sulfamide- and 3′-N-sulfamate-modified DNAElectronic supplementary information (ESI) available: typical melting curves obtained from thermal denaturation of modified oligonucleotides with complementary DNA and RNA. See http://www.rsc.org/suppdata/p1/b1/b110603c

Perkin 1 : an international journal of organic and bio-organic chemistry, 2002-02 (4), p.485-495

2002

Volltextzugriff (PDF)

O2–06–04: A liposomal anti‐phospho‐tau vaccine demonstrates higher immunogenicity and specificity than a classical peptide vaccine approach

Alzheimer's & dementia, 2013-07, Vol.9 (4S_Part_8), p.P326-P326

2013

Volltextzugriff (PDF)

P2‐525: Novel phospho‐Tau specific monoclonal antibodies for the treatment of Tau‐mediated pathology

Alzheimer's & dementia, 2011-07, Vol.7 (4S_Part_14), p.S480-S480

2011

Volltextzugriff (PDF)

1 – 25 von 804

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

ThemaTechnology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(695)
Mit Volltextzugriff
(689)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(429)
Life Sciences & Biomedicine
(361)
Humans
(266)
Female
(147)
Male
(137)
Animals
(100)
Biological And Medical Sciences
(84)
Adult
(79)
Medical Sciences
(69)
Middle Aged
(68)
Mice
(59)
Physical Sciences
(50)
Aged
(46)
General & Internal Medicine
(44)
Medicine, General & Internal
(42)
Pharmacology & Pharmacy
(38)
Multidisciplinary Sciences
(36)
Science & Technology - Other Topics
(36)
Infectious Diseases
(33)
Adolescent
(32)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies

Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathy

Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice

Engineering amyloid-like assemblies from unstructured peptides via site-specific lipid conjugation

Discovery and characterization of novel indole and 7-azaindole derivatives as inhibitors of β-amyloid-42 aggregation for the treatment of Alzheimer’s disease

Sequence-independent Control of Peptide Conformation in Liposomal Vaccines for Targeting Protein Misfolding Diseases

Novel Phospho-Tau Monoclonal Antibody Generated Using a Liposomal Vaccine, with Enhanced Recognition of a Conformational Tauopathy Epitope

TLR4- and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T cell–independent isotype switch in mice

A liposomal anti-phospho-tau vaccine demonstrates higher immunogenicity and specificity than a classical peptide vaccine approach

Immunization with liposome-anchored pegylated peptides modulates doxorubicin sensitivity in P-glycoprotein-expressing P388 cells

Phospho-tau–specific vaccine for the treatment of tau pathology

Novel phospho-Tau specific monoclonal antibodies for the treatment of Tau-mediated pathology

The safety profile of ACI-24, an oligo-specific amyloid beta vaccine, demonstrated decrease of large microbleedings in brain of aged Alzheimer's disease mouse model

Nucleic acid binding properties of thyminyl and adeninyl pyrrolidine-amide oligonucleotide mimics (POM)

Design, synthesis, conformational analysis and nucleic acid hybridisation properties of thymidyl pyrrolidine-amide oligonucleotide mimics (POM)

An Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome

Design, synthesis, conformational analysis and nucleic acid hybridisation properties of thymidyl pyrrolidine-amide oligonucleotide mimics (POM)Electronic supplementary information (ESI) available: experimental details (16 Figures, 3 Tables). See http://www.rsc.org/suppdata/ob/b3/b306156f

Discovery and preclinical characterization of 18FPI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies

An Anti-[beta]-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome

Synthesis and nucleic-acid-binding properties of sulfamide- and 3 '-N-sulfamate-modified DNA

A general route for the synthesis of triazacyclononane functionalised with one, two or three pendant phosphine arms: crystal structure of [Zn2L2Cl3][ClO4], L =N-(diphenylphosphinopropyl)-1,4,7-triazacyclononane

O2–06–04: A liposomal anti‐phospho‐tau vaccine demonstrates higher immunogenicity and specificity than a classical peptide vaccine approach

P2‐525: Novel phospho‐Tau specific monoclonal antibodies for the treatment of Tau‐mediated pathology

Aktive Filter

Suchergebnisse filtern